NIH Weekly Funding Opportunities and Policy Notices
Funding Opportunity RFA-MH-24-106 from the NIH Guide for Grants and Contracts. The proposed U24 funding opportunity, along with the companion proposal for P01 regional early psychosis networks, extends NIMH support for large-scale T3/T4 translational research that aims to improve early identification, intervention effectiveness, and long-term outcomes for youth and young adults experiencing an initial episode of psychosis.
Notice NOT-NS-24-036 from the NIH Guide for Grants and Contracts
Notice NOT-OD-24-030 from the NIH Guide for Grants and Contracts
Funding Opportunity PAR-24-044 from the NIH Guide for Grants and Contracts. (Reissue of PAR-18-617) The purpose of this funding opportunity announcement (FOA) is to provide a vehicle for Small Business Concerns (SBCs) submitting Small Business Technology Transfer (STTR) grant applications for investigator-initiated exploratory clinical trials to the National Institute of Neurological Disorders and Stroke (NINDS). The projects must focus on products related to the mission and goals of the NINDS and may evaluate drugs, biologics, devices, or diagnostics, as well as surgical, behavioral or rehabilitation therapies. Only STTR Phase II and Fast-Track applications are supported under this program. STTR Phase I applications are only accepted as part of a Fast-track application.
Funding Opportunity PAR-23-311 from the NIH Guide for Grants and Contracts. (Reissue of PAR-21-266) The purpose of this funding opportunity announcement (FOA) is to provide a vehicle for Small Business Concerns (SBCs) submitting Small Business Innovation Research (SBIR) grant applications for investigator-initiated exploratory clinical trials to the National Institute of Neurological Disorders and Stroke (NINDS). The projects must focus on products related to the mission and goals of the NINDS and may evaluate drugs, biologics, devices, or diagnostics, as well as surgical, behavioral or rehabilitation therapies. Only SBIR Phase II and Fast-Track applications are supported under this program. SBIR Phase I applications are only accepted as part of a Fast-track application.
Funding Opportunity RFA-RM-23-014 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs. To accomplish the stated overarching goal, this NOFO will support creative educational activities with a primary focus on: Courses to equip users to interact with and use Common Fund data in rigorous biomedical research Mentoring and networking to support the growth of a diverse multi-disciplinary community of Common Fund data users
Funding Opportunity RFA-MH-24-105 from the NIH Guide for Grants and Contracts. The current initiative builds upon these FOAs but utilizes the P01 activity code to support separate research projects for (1) promoting measurement-based care in real-world treatment settings and (2) addressing unanswered questions about early intervention in psychosis, including new approaches for improving patient engagement, sustaining treatment gains over time, and advancing equity in treatment access, service delivery, and clinical/functional outcomes.
Notice NOT-HD-23-037 from the NIH Guide for Grants and Contracts
Notice NOT-GM-24-010 from the NIH Guide for Grants and Contracts
Notice NOT-MD-23-022 from the NIH Guide for Grants and Contracts
Notice NOT-DC-24-010 from the NIH Guide for Grants and Contracts
Funding Opportunity PA-23-317 from the NIH Guide for Grants and Contracts. The National Institutes of Health (NIH) hereby notifies NIH award recipients that funds may be available for revision applications to support the expansion of existing projects and/or programs within the awarding IC identified in the competitive revision Notice of Special Interest (NOSI). Applications for Revisions will be evaluated for scientific and technical merit by (an) appropriate Scientific Review Group(s), in accordance with NIH peer review policy and procedures, using the stated review criteria. Only applications submitted in response to a NOSI published by an NIH Institute or Center will be allowed to apply to this NOFO.
Funding Opportunity PAR-24-073 from the NIH Guide for Grants and Contracts. This NIH Research Career Enhancement Award (K18) program invites applications from experienced investigators seeking to redirect or expand their research programs through the acquisition of new skills and knowledge in the area of firearm mortality and injury prevention research, which is beyond and complementary to their current areas of expertise. The program will support research training and career development experiences and a small-scale research project that will provide experienced investigators with the scientific competencies required to conduct research relevant to firearm morality and injury prevention research. Eligible candidates are independent investigators at any faculty rank or level. The proposed project must be related to the programmatic interests of one or more of the participating NIH Institutes and Centers (ICs) based on their scientific missions. This Notice of Funding Opportunity (NOFO) is designed specifically for applicants proposing to serve as the lead investigator of an independent clinical trial, a clinical trial feasibility study, or a separate ancillary study to an existing trial, as part of their research and career development. Applicants not planning an independent clinical trial, or proposing to gain research experience in a clinical trial led by another investigator, must apply to companion NOFO (TEMP 24908).
Funding Opportunity PAR-24-070 from the NIH Guide for Grants and Contracts. This NIH Research Career Enhancement Award (K18) program invites applications from experienced investigators seeking to redirect or expand their research programs through the acquisition of new skills and knowledge in the area of firearm mortality and injury prevention research, which is beyond and complementary to their current areas of expertise. The program will support research training and career development experiences and a small-scale research project that will provide experienced investigators with the scientific competencies required to conduct research relevant to firearm morality and injury prevention research. Eligible candidates are independent investigators at any faculty rank or level. The proposed project must be related to the programmatic interests of one or more of the participating NIH Institutes and Centers (ICs) based on their scientific missions. This Notice of Funding Opportunity (NOFO) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial. Under this NOFO applicants are permitted to propose a research experience in a clinical trial led by a mentor or co-mentor. Those proposing a clinical trial or an ancillary clinical trial as lead investigator, should apply to the companion NOFO (NOFO #).
Funding Opportunity PAR-24-068 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) focuses on prevention and intervention strategies for fetal alcohol spectrum disorders (FASD) throughout the lifespan. The intent of this NOFO is to support research that advances (1) prevention approaches to reduce prenatal alcohol exposure and the incidence of FASD and that (2) interventions for FASD. These objectives will be accomplished with the Exploratory/Developmental Phased Award (R61/R33) mechanism, clinical trial optional. The R61 phase will support pilot studies or secondary data analysis for hypothesis development and feasibility, and research testing the hypotheses can be expanded in the R33 phase. The transition to the R33 phase will be determined by NIAAA program staff after evaluation of the achievement of specific milestones set for the R61 phase. Highest priority will be given to applications with clinical trials. Applicants interested in planning clinical trials or adding to current projects may also consider NOFO (TEMP-23832, the R34 option).
Funding Opportunity PAR-24-067 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) for R34 planning grant applications focuses on prevention and intervention strategies for fetal alcohol spectrum disorders (FASD) throughout the lifespan. The intent of this NOFO is to support research that advances (1) prevention approaches to reduce prenatal alcohol exposure and incidence of FASD and (2) interventions for FASD. It is expected that research conducted via this mechanism will consist of studies that are a pre-requisite for preparing and submitting subsequent applications for larger scale FASD prevention or intervention studies. Applicants interested in exploratory phased projects may consider NOFO (TEMP-23833, the R61/R33 option).
Notice NOT-GM-24-007 from the NIH Guide for Grants and Contracts
Notice NOT-DA-23-046 from the NIH Guide for Grants and Contracts
Notice NOT-NS-24-032 from the NIH Guide for Grants and Contracts
Notice NOT-EB-23-020 from the NIH Guide for Grants and Contracts